Parkinson's Disease: Animal Models

Parkinson’s disease is a progressive neurodegenerative disorder that affects movement. This feed focuses on animal models used for Parkinson's disease research.

September 12, 2020

Vitamin D attenuated 6-OHDA-induced behavioural deficits, dopamine dysmetabolism, oxidative stress, and neuro-inflammation in mice

Nutritional Neuroscience
Adedamola Bayo-OlugbamiBamidele Victor Owoyele
September 9, 2020

Chronic jaw pain attenuates neural oscillations during motor-evoked pain

Brain Research
Wei-En WangStephen A Coombes
September 15, 2020

Squalamine Restores the Function of the Enteric Nervous System in Mouse Models of Parkinson's Disease

Journal of Parkinson's Disease
Christine L WestWolfgang A Kunze
September 8, 2020

Wedelolactone Mitigates Parkinsonism Via Alleviating Oxidative Stress and Mitochondrial Dysfunction Through NRF2/SKN-1

Molecular Neurobiology
Shruti SharmaRakesh Pandey
September 15, 2020
Review
Open Access

The complex relationship between genotype, pathology and phenotype in familial dementia

Neurobiology of Disease
John B KwokGlenda M Halliday
September 13, 2020
Open Access

Roles of lysosomotropic agents on LRRK2 activation and Rab10 phosphorylation

Neurobiology of Disease
Tomoki KuwaharaTakeshi Iwatsubo
September 17, 2020

Ameliorative effects of flavonoids and polyketides on the rotenone induced Drosophila model of Parkinson's disease

Neurotoxicology
Angela A SiimaStephen S Nyandoro
September 15, 2020
Review
Open Access

Optogenetic TDP-43 nucleation induces persistent insoluble species and progressive motor dysfunction in vivo

Neurobiology of Disease
Charlton G OtteChristopher J Donnelly
September 13, 2020
Review

Effect of statins on amyloidosis in the rodent models of Alzheimer's disease: Evidence from the preclinical meta-analysis

Brain Research
Syed Obaidur RahmanAbul Kalam Najmi
September 18, 2020
Review

A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review

European Journal of Medicinal Chemistry
Shoaib Manzoor, Nasimul Hoda
September 9, 2020

Overexpressed PERK suppresses the neurodegenerative phenotypes in PINK1B9 flies by enhancing mitochondrial function

Neurochemistry International
Ying CuiQinghua Li
September 9, 2020

Cranial Irradiation Impairs Juvenile Social Memory and Modulates Hippocampal Physiology

Brain Research
Jamila NewtonAntiño R Allen
September 15, 2020

Neuroprotective effect of rhaponticin against Parkinson disease: Insights from in vitro BV-2 model and in vivo MPTP-induced mice model

Journal of Biochemical and Molecular Toxicology
Fangfang ZhaoHongan Yang

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/parkinsons-disease-animal-models/e27795a9-e2a0-4cc0-b26e-e7521eb7a43d